Pipeline

Pipeline

iO Bio’s pipeline has an initial clinical focus in oncology and in particular liver cancer.

 
Discovery
Preclinical
In-House
 
In-License: Liver Cancer
 
In License: Pan-Cancer
 

Partnering

We seek partners interested in using our GEMS™ technology to develop an off-the-shelf CAR therapy portfolio. iO BiO’s technology is ideally suited to rapidly convert autologous CARs into an off-the-shelf CAR portfolio with any universal cell

Vision for GEMS™

iO BiO Sciences Investors

Contact Sicco Popma for investment opportunities